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1. JAM-A harbored by leukocytes and endothelial cells display opposite functions 
with distinct outcomes for atherosclerotic lesion formation (this dissertation).  
 
2. Re-localization of endothelial JAM-A from junctions to the apical site of 
endothelial cells is an important mechanism driving atherogenic leukocyte 
recruitment to the vessel wall (this dissertation). 
 
3. MicroRNA-145 prevents endothelial JAM-A expression in vessels with high and 
laminar shear stress (this dissertation). 
 
4. Lowering both endothelial JAM-A re-localization and inflammatory leukocyte 
recruitment is a novel atheroprotective effect of lovastatin (this dissertation). 
 
5. The luminal expression of JAM-A under atherogenic conditions should be 
developed as a target for molecular imaging (this dissertation). 
 
6. Blockade of JAM-A homophilic interactions and subsequent platelet adhesion to 
inflamed endothelium allows design of novel classes of anti-atherosclerotic and 
anti-thrombotic drugs. (Babinska et al., 2014, Biopolymers) 
 
7. Two-photon laser scanning microscopy: Seeing is believing! 
 
8. Am Ende des Tages muss nur eine Antwort stehen: Geht oder geht nicht. 
At the end of the day you only need one answer: Feasible or not. 
(nach Peter Grünberg) 
 
9. Experience is what you get when you didn’t get what you wanted.  
(Randy Pausch) 
 
10. Und wünsch mir mehr zu sagen an mein‘ jüngsten Tag, 
also von Mutterleib ins Grab ´ne gute Zeit gehabt. 
(Retrospektive, Freundeskreis) 
